Overview
Injective vs PC0000077 is one of the most watched crypto matchups. Beyond headline prices, this comparison blends market structure, technical readings and probabilistic context without promising outcomes.
Quick winners
Full comparison
| Metric | INJ | PC0000077 |
|---|---|---|
| Price | $5.02 | $1,865.83 |
| Market Cap | $490.41M | $100.00M |
| FDV | — | — |
| Volume 24h | $2.97M | $0.000000 |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 99.00 | 254.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.78% | +3.50% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | INJ | PC0000077 |
|---|---|---|
| 1H | — | — |
| 24H | +1.64% | +0.00% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | INJ | PC0000077 |
|---|---|---|
| RSI | 53.92 | 54.31 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.29 | 66.45 |
| ADX | 12.69 | 20.44 |
| Support | 4.91 | 1,827.82 |
| Resistance | 5.47 | 1,960.30 |
| Trend | neutral | bearish |
| Momentum | — | 60.00 |
| Signal | neutral | neutral |
Automatic technical analysis
When RSI and trend disagree across Injective and PC0000077, expect choppy relative performance until one side reclaims a clear structure.
Fundamentals
| Metric | INJ | PC0000077 |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 0.00 | — |
| Github activity | 118.00 | — |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Injective
PC0000077
Pros and cons
Pros of Injective
- Higher ranking for Injective can translate into tighter spreads on major venues.
- Injective has an established coin page footprint on PEPS for continuous monitoring.
- INJ often anchors narratives that attract sustained media and analyst coverage.
Cons of Injective
- When dominance narratives fade, Injective can lag hotter rotation names.
- Large-cap status for Injective can mean slower percentage upside versus high-beta alternatives.
- Crowded positioning around INJ sometimes amplifies squeeze or flush risk.
Pros of PC0000077
- Active volume bursts on PC0000077 sometimes precede sharper tactical moves.
- Diversifying versus Injective with PC0000077 can change portfolio factor exposure.
- PEPS tracking for PC0000077 still includes AI score and level context for monitoring.
- Narrative optionality around PC0000077 can reprice quickly when catalysts appear.
Cons of PC0000077
- Trend failures on PC0000077 often travel faster than on more established assets.
- Weaker market-cap standing may leave PC0000077 more exposed to liquidity droughts.
- Incomplete fundamental coverage can hide operational or tokenomic risks.
- Smaller book depth versus large caps can increase slippage for PC0000077.
Which looks stronger right now?
The “stronger” label here is descriptive, not predictive. Injective and PC0000077 can alternate leadership as macro liquidity and narrative rotate.
AI summary
PEPS synthesizes module output into a readable pair brief. Headline stats put Injective at $5.02 and PC0000077 at $1,865.83. Relative performance over 24h (Injective) is a short window. Pair it with 30d/1y rows before inferring regime change. Return to related comparisons and individual coin intelligence pages to validate whether the relative story still holds after fresh prints.
FAQ
Which is better, Injective or PC0000077?
“Better” depends on horizon and risk. Injective leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, INJ or PC0000077?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Injective and PC0000077.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.